/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
- Profitability initiatives drive margin expansion; Location count surpasses 1,000 early...
YANTAI, China, Aug. 13, 2025 /PRNewswire/ -- On August 13th, Remegen (688331.SH/09995.HK) announced that its global first-in-class BLyS (BAFF)/APRIL dual-target fusion protein drug, Telitacicept, met...
Marks fifth consecutive year of improvement, ranking in the top 23% of the Manufacture of Pesticides and Other Agrochemical Products industry – including top...